The Culture Survey Nobody Wanted to See

Yes, it is a board matter, for three reasons.

1. It is a risk signal, not just an HR metric. In a care business, the product is the conduct of front-line staff. A workforce that is afraid to report medication errors is a patient-safety and regulatory risk. The board's risk oversight is engaged whether or not it wishes to be.
2. The pattern is coherent, not random. Low psychological safety (41%), low managerial responsiveness (38%) and low advocacy (46%) point to the same cause: people do not believe speaking up changes anything, and some fear their manager. The free text names a specific regional manager and a specific behaviour (intimidation) and a specific consequence (under-reporting of medication errors). That is a triangulated signal.
3. Turnover confirms it. 34% against a 27% sector average is a 7-point gap. At 3,200 staff, that gap represents roughly 220 additional leavers a year, with recruitment and training costs, agency cover costs, and continuity-of-care impacts. The cost is likely to exceed the $180,000 recognition programme by a wide margin.

What the pattern suggests

• A speak-up problem, not a morale problem. Recognition programmes address the second, not the first.
• A management behaviour problem concentrated in at least one region. The board should want to know whether complaints or exit interviews cluster around the same manager.
• A policy-practice gap. A whistleblowing policy with zero recorded uses in three years is almost never evidence of a healthy culture; it usually indicates the channel is not trusted or not known.

The "not a board matter" view mistakes the subject matter (people) for the level of oversight. The board does not need to run the recognition programme; it does need to satisfy itself that the culture is consistent with the strategy and the risk appetite.

What the board does itself

• Put culture on the agenda as a standing item with real time, not a footnote.
• Have the people committee meet front-line staff and first-line supervisors at least twice a year, without regional management present, and report to the full board.
• Receive the full survey free-text analysis, theme-coded, with counts, and trend data across at least three years.
• Ask for the exit-interview themes and the grievance and whistleblowing logs, anonymised, with case outcomes and time to close.
• Satisfy itself that the whistleblowing channel is independently operated, is known to staff, and has a route to the committee chair.

What it requires of management

• A specific investigation into the named regional manager, run independently of that manager's chain of command, with a report to the committee.
• A root-cause analysis of medication-error reporting: is the low reporting a sign of fewer errors or of fear? Compare reported rates against expected rates.
• A costed retention plan that addresses rota pressure and supervisory behaviour, not only recognition. Ask management to show the business case for the $180,000 programme against the cost of turnover.
• A revised speak-up campaign with visible senior sponsorship and a commitment to publish anonymised outcomes.

How to measure change

• Leading indicators: number of concerns raised (a rising number is initially a good sign), time to acknowledge and close, percentage of staff who know how to raise a concern, medication-error reporting rate moving toward expected levels.
• Lagging indicators: the three survey items, turnover versus sector, agency spend, exit-interview themes.
• Set a target and a review date: for example, a 10-point improvement in the speak-up item within 12 months, reviewed quarterly by the committee.

The test: if the only output is a recognition programme and a warmer summary next year, the board has not governed the issue.

Acknowledge the true part. Sector-wide retention pressure is real, and the board should not pretend otherwise. Conceding the true part makes the challenge harder to dismiss.

Then separate the two questions.

• Is the sector difficult? Yes.
• Does that explain our position? Not entirely. The company is 7 points worse than the sector average. The sector comparison sets the benchmark; it does not excuse the gap. Ask: "If the whole sector is at 27%, what explains our 34%?"

Use data rather than assertion.

• Ask for turnover broken down by home, by tenure and by manager. If one or two homes account for a disproportionate share, the problem is local and fixable, not climatic.
• Ask for the same breakdown for the survey items. If the three low scores cluster by region, the "industry-wide" explanation weakens.
• Ask what the cost of the gap is: agency cover, recruitment, induction, and the quality impact. A number changes the conversation from values to value.

Stay at the level of oversight.

• Do not design the rota or select the recognition vendor. Ask management what it proposes, what it will cost, and how the board will know whether it worked.
• Frame the challenge as a request for a plan that matches the diagnosis: "The diagnosis in the survey is speak-up and supervision. The proposed remedy is recognition. Help us understand how the remedy addresses the diagnosis."
• Ask the CEO what would change his mind, and what evidence would show the industry explanation is wrong. A good executive will engage; a defensive one will reveal that the framing is doing protective work.

The governance principle: Directors challenge the logic and the evidence, not the operational choices. The line is crossed when a director starts directing staff; it is not crossed by insisting that the explanation fit the data.